AMINO ACID URINE - QUANTITATIVE

The AMINO ACID URINE - QUANTITATIVE test measures the amounts of multiple amino acids excreted in urine. Amino acids are filtered from the blood by the kidneys, and most are normally reabsorbed by the kidney tubules. Abnormal quantities or patterns in urine may develop when amino acid metabolism is disrupted, when a specific transport system does not work correctly or when the kidney tubules cannot adequately reabsorb filtered amino acids.

Quantitative urine amino acid analysis may help identify inherited metabolic disorders, selective amino acid transport defects and generalized renal aminoaciduria. It is often interpreted alongside quantitative plasma amino acids because an increased urine concentration can result either from a high blood level or from impaired kidney reabsorption. The overall pattern is usually more informative than one isolated result.

Benefits of the Test

• Quantitatively measures multiple amino acids excreted in urine.
• Supports investigation of inherited amino acid metabolism disorders.
• Helps identify selective renal transport defects such as cystinuria.
• May reveal generalized aminoaciduria associated with proximal tubular dysfunction.
• Supports monitoring of selected confirmed metabolic conditions.
• Guides additional plasma, biochemical and genetic investigations.

Why Doctors Recommend This Test

A paediatrician, nephrologist, neurologist, clinical geneticist or metabolic specialist may recommend the test when a patient has unexplained developmental delay, poor growth, seizures, recurrent vomiting, kidney stones, unusual urine findings or laboratory evidence of kidney-tubule dysfunction. It may also be ordered after an abnormal newborn screening or plasma amino acid result.

Distinct urinary patterns can support evaluation for disorders such as cystinuria, Hartnup disorder, lysinuric protein intolerance and other selective transport defects. In cystinuria, excessive urinary excretion of cystine and certain dibasic amino acids increases the risk of recurrent cystine kidney stones. A broad increase across many amino acids can occur in generalized proximal tubular dysfunction, including Fanconi syndrome.

Abnormal urinary amino acids may also appear secondarily due to liver disease, kidney disease, malnutrition, medication, prematurity, serious illness or an elevated concentration in the blood. Consequently, the test does not independently establish a genetic diagnosis. Doctors review the pattern with clinical findings, plasma amino acid concentrations and other investigations.

Preparation Before Test

Collection requirements depend on whether the laboratory requests a random urine specimen or a timed collection such as a 24-hour sample. Confirm the exact collection method, required container, preservative, minimum volume, storage temperature and transportation instructions before starting. Do not begin a 24-hour collection unless it has been specifically requested.

Inform the doctor about special diets, protein or amino acid supplements, vitamins, medicines and recent illness. These factors can affect urinary amino acid excretion. Do not stop prescribed treatments unless advised by the treating doctor. Avoid contaminating the specimen with stool, toilet water, tissue paper or cleaning products. For infants, use only the collection method provided or approved by the healthcare team.

When a 24-hour collection is required, all urine passed during the specified period must be included according to the laboratory's written instructions. Missing even one sample can make the result inaccurate. If a random sample is requested, the laboratory may report amino acid values relative to urinary creatinine to account for differences in urine concentration.

Normal Reporting Time

Quantitative urine amino acid analysis is a specialized metabolic test and generally requires several working days. Reporting time varies according to specimen transport, sample quality, analytical scheduling, the number of amino acids measured and whether repeat or confirmatory analysis is needed. Focus Diagnostics will provide the applicable turnaround estimate when the specimen is submitted.

Who Should Take This Test?

• Patients with suspected inherited amino acid metabolism or transport disorders.
• People with recurrent kidney stones and possible cystinuria.
• Children with unexplained developmental delay, poor growth or neurological symptoms.
• Patients with suspected renal tubular dysfunction or Fanconi syndrome.
• Individuals with abnormal plasma amino acid or newborn-screening results.
• Patients requiring monitoring of an established metabolic condition.
• Anyone referred by a metabolic specialist, nephrologist or clinical geneticist.

Detailed Information

The analysis identifies and measures individual amino acids rather than only reporting their presence. Results may be expressed as a concentration, as excretion over a timed collection or relative to urinary creatinine. Age-specific and method-specific reference intervals are necessary because amino acid excretion varies between newborns, children and adults.

Plasma and urine findings must be considered together. When an amino acid is elevated in both plasma and urine, the urinary increase may reflect overflow from the blood. When plasma concentration is normal but urinary excretion is disproportionately high, a renal transport defect may be considered. A generalized increase involving many amino acids may suggest proximal tubular dysfunction but requires confirmation with other kidney-related tests.

Additional investigations may include quantitative plasma amino acids, urine organic acids, acylcarnitine profile, blood ammonia, lactate, kidney and liver function tests, urine glucose, phosphate, bicarbonate and other markers of tubular function. In suspected cystinuria, stone analysis, imaging and targeted genetic testing may be recommended. Molecular testing may also confirm other inherited transport or metabolic disorders.

Treatment depends on the confirmed diagnosis. It may include increased fluid intake, dietary modification, urine alkalinisation, medicines to prevent cystine stones, replacement of substances lost through the kidneys or disease-specific metabolic treatment. Dietary restrictions and supplements should only be used under specialist and metabolic-dietitian supervision.